Publications by authors named "Pierre P Major"

Claim this Profile
L
Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy.
Himanshu R Lukka, Stephanie L Pugh, William U Shipley, Pierre P Major, Oliver Sartor

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer.
Lisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, Robert C Mould, Jacob G E Yates, Pierre P Major

Front Microbiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma.
Ashley A Stegelmeier, Lisa A Santry, Matthew M Guilleman, Kathy Matuszewska, Jessica A Minott, Pierre P Major

Biomedicines· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.
Bryce M Warner, Lisa A Santry, Alexander Leacy, Mable Chan, Phuc H Pham, Pierre P Major

iScience· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models.
Thomas M McAusland, Jacob P van Vloten, Lisa A Santry, Matthew M Guilleman, Amira D Rghei, Pierre P Major

Mol Ther Oncolytics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour vasculature: Friend or foe of oncolytic viruses?
Lisa A Santry, Jacob P van Vloten, Jason P Knapp, Kathy Matuszewska, Thomas M McAusland, Pierre P Major

Cytokine Growth Factor Rev· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer.
Kathy Matuszewska, Lisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, Pierre P Major

Clin Cancer Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer.
Lisa A Santry, Thomas M McAusland, Leonardo Susta, Geoffrey A Wood, Pierre P Major

Mol Ther Methods Clin Dev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, Pierre P Major, Niall M Heney

N Engl J Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.
Harm Westdorp, Annette E Sköld, Berit A Snijer, Sebastian Franik, Sasja F Mulder, Pierre P Major

Front Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trials.
Robert E Coleman, Allan Lipton, Luis Costa, Richard J Cook, Ker-Ai Lee, Pierre P Major

J Bone Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
Pierre P Major, Richard J Cook, Allan Lipton, Matthew R Smith, Evangelos Terpos

BMC Cancer· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
Luis Costa, Pierre P Major

Nat Clin Pract Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity.
Vera Hirsh, Pierre P Major, Allan Lipton, Richard J Cook, Corey J Langer

J Thorac Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An optimized clinical regimen for the oncolytic virus PV701.
Sébastien J Hotte, Robert M Lorence, Hal W Hirte, Susan R Polawski, Michael K Bamat, Pierre P Major

Clin Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival-adjusted multiple-event analysis for the evaluation of treatment effects of zoledronic Acid in patients with bone metastases from solid tumors.
Pierre P Major, Richard J Cook, Bee-Lian Chen, Ming Zheng

Support Cancer Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer.
Mary J Mackenzie, Holger W Hirte, Goss Glenwood, Maroun Jean, Rakesh Goel, Pierre P Major

Invest New Drugs· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of phase I studies of intravenous administration of PV701, an oncolytic virus.
Robert M Lorence, Andrew L Pecora, Pierre P Major, Sebastien J Hotte, Scott A Laurie

Curr Opin Mol Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.
Pierre P Major, Richard Cook

Am J Clin Oncol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis